"heart disease"

The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.

Graham's death sparks questions on cardiac arrest that is caused by an electrical malfunction in the heart that disrupts its pumping action....

A recent study by the World Heart Foundation (WHF) highlighted the links between air pollution and congenital heart disease, which is someti...

South Carolina’s In Our DNA SC program brings free genomic screening to all 46 counties, uncovering hidden cancer and heart risks early enou...

'The Pitt' leads Emmy nominations with 25 nods, but the medical drama's bigger achievement is teaching millions of Americans about health an...

The report by the UK100 group of councils claims local work around tacking air pollution between 2019 and 2025 prevented an estimated 13,722...

The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ingredients to drugs. It...

The U.S. spends a lot on healthcare — in terms of total and per capita expenditures and patient out-of-pocket costs — but gets a relatively...

Upheaval at the U.S. Preventive Services Task Force may reshape coverage of preventive care by insurance, possibly leading to removal of pre...

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger...

The best Medicare plan is not always the cheapest. It is the one that still works when your health needs change.

Whether American healthcare reorganizes around prevention will be a test of the quality of its leadership.